Anna's Deep Dives

_{Just facts, you think for yourself}

What is gene editing, and how does it work? How close are we to curing all genetic diseases? Who decides what’s ethical when the power to rewrite DNA is in our hands?

Gene editing is no longer science fiction. In late 2023, the FDA approved Casgevy, the first CRISPR-based therapy for sickle cell disease—93.5% of patients are now pain-free. Scientists are editing immune cells to fight cancer, modifying crops to survive drought, and even using gene drives to wipe out invasive species.

But this power comes with consequences. Editing embryos could stop inherited diseases—or create a new era of eugenics. Designer babies, bioengineered viruses, edited pig organs, and synthetic bacteria are all now within reach. Some countries are racing ahead. Others are calling for global bans.

This deep dive explores the full scope of gene editing across medicine, agriculture, and biotechnology. We gathered insights from 2,174 sources to answer the biggest questions:

• What’s happening inside CRISPR-edited cells right now—and what could go wrong?

• How will gene editing reshape global food systems as climate change accelerates?

• Who owns the future of gene editing: startups, governments, or Big Pharma?

• What are the business models, the breakthrough therapies, and the billion-dollar risks?

• Where do we draw the line between therapy and enhancement?

From Nobel-winning discoveries to the fight against rare disease, from the lab to the law, we trace the rise of gene editing and where it’s headed next.

If we’ve done our job, you’ll walk away with a clear, grounded understanding of how this technology works, why it matters, and what’s at stake as we enter the age of engineered evolution.

Why Gene Editing Matters

Gene editing allows scientists to rewrite DNA. CRISPR, the most advanced tool, makes precise changes to genetic code faster and cheaper than ever before.

Global food demand is rising. By 2050, the world’s population will reach 9.3 billion, requiring a 60% increase in food production. Climate change makes this harder, causing droughts, heat waves, and crop failures. Gene-edited crops can resist harsh conditions, boosting food security.

Casgevy was the first CRISPR-based treatment for sickle cell disease and beta thalassemia. The treatment works for 93.5% of patients, eliminating severe pain. But at $2.2 million per patient, it raises concerns about affordability.

Gene editing may help cure cancer, HIV, and rare genetic disorders. Scientists have used CAR-T cell therapy to modify immune cells, leading to a 77% disease control rate in kidney cancer. CRISPR is also improving diagnostic tools, creating faster, more precise disease tests.

Ethical concerns surround gene editing. In 2018, a scientist in China edited human embryos to resist HIV. The experiment led to international backlash and a prison sentence. Fear of “designer babies” and genetic inequality remains a major debate.

The gene editing industry is growing fast. In 2022, the market was worth $5.1 billion. By 2030, it could reach $16.2 billion. This growth reflects the increasing use of gene editing in medicine, agriculture, and conservation.

Over 1 million species face extinction. Scientists are using CRISPR to protect biodiversity by controlling invasive species and reviving endangered populations. Some researchers even explore editing genes to slow aging in humans.

We don’t take shortcuts, chase headlines, or push narratives. We just bring you the news, straight and fair. If you value that, click here to become a paid subscriber—your support makes all the difference.

Table of Contents

(Click on any section to start reading it)

2. The Science of Gene Editing

DNA 101: The Blueprint of Life

How Mutations Shape Evolution & Disease

Early Gene Editing Techniques: The Precursors to CRISPR

CRISPR & Beyond: How Gene Editing Works Today

3. The History of Gene Editing

The Discovery of DNA & the Genetic Code

The Rise of Genetic Engineering: From GMOs to Gene Therapy

CRISPR’s Breakthrough: A Nobel Prize-Winning Revolution

4. The Applications of Gene Editing

Medicine & Human Health

Curing Genetic Diseases: Sickle Cell, Cystic Fibrosis, and Beyond

The Promise of Cancer Treatments

Organ Transplants & Xenotransplantation (Editing Pig Organs for Humans)

The Emerging Field of Epigenetic Editing

Agriculture & Food Production

Genetically Modified Crops vs. CRISPR-Edited Crops

Engineering Disease-Resistant Livestock

The Fight Against Food Insecurity & Climate Change

Biotechnology & Synthetic Biology

Gene Editing for Drug Development

Biomanufacturing: Editing Bacteria to Produce Medicine

Engineering New Life Forms

5. The Business of Gene Editing

The Race for Patents: Who Owns CRISPR?

The Leading Gene Editing Companies & Their Technologies

The Economics of Gene Therapies: Can We Make It Affordable?

Investing in Gene Editing: Risks & Opportunities

6. The Ethical Dilemmas of Gene Editing 

Designer Babies & Human Enhancement

The Risk of Eugenics & Genetic Discrimination

Should We Edit the Human Germline?

Regulating a Global Technology: Who Decides What’s Ethical?

7. The Risks & Challenges of Gene Editing

Off-Target Effects & Unintended Consequences

Biosecurity Concerns: Could CRISPR Be Weaponized?

The Challenge of Public Acceptance & Misinformation

8. The Future of Gene Editing

CRISPR 2.0 & Next-Gen Technologies

The Path to Curing All Genetic Diseases

The Ultimate Ethical Dilemma: Should We Edit Ourselves to Evolve?

Baked with love,

Anna Eisenberg ❤️